TY - JOUR
T1 - A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination
T2 - findings from 33 hepatitis elimination profiles
AU - Hiebert-Suwondo, Lindsey
AU - Manning, Jana
AU - Tohme, Rania A.
AU - Buti, Maria
AU - Kondili, Loreta A.
AU - Spearman, C. Wendy
AU - Hajarizadeh, Behzad
AU - Turnier, Victoria
AU - Lazarus, Jeffrey V.
AU - Grebely, Jason
AU - Dore, Gregory J.
AU - Waked, Imam
AU - Ward, John W.
AU - Miranda, Angelica
AU - Sugiyama, Aya
AU - Varaldo, Carlos
AU - Thomas, Caroline
AU - Muñoz, Chris
AU - Desalegn, Hailemicahel
AU - Aberra, Hanna
AU - Cheinquer, Hugo
AU - Qureshi, Huma
AU - Ivanchuk, Irina
AU - García-Samaniego, Javier
AU - Tanaka, Junko
AU - Tint, Khin San
AU - Poovorawan, Kittiyod
AU - De Feo, María Eugenia
AU - Sonderup, Mark
AU - Aleksandrova, Maryna
AU - Ali, Mohammad
AU - Hassany, Mohamed
AU - Desai, Monica
AU - Prabdial-Sing, Nishi
AU - Marinho, Rui
AU - Hamid, Saeed
AU - Punpetch, Samart
AU - Naing, Thandar Su
AU - Tanaka-Kumadai, Yasu
AU - Lim, Young Suk
AU - Nartey, Yvonne
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/7
Y1 - 2025/7
N2 - The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development for the elimination of viral hepatitis. To date, profiles from 33 countries and territories have been developed. These profiles reveal that 30 (91%) countries and territories have hepatitis C national action plans, 11 (33%) have systems to monitor hepatitis C-related mortality, 16 (48%) have systems to monitor hepatitis C incidence, and 18 (55%) have systems to track the number of people tested and treated. Some countries and territories continue to uphold barriers to hepatitis C treatment, with 12 (36%) still having partial or full restrictions on prescribing authority for non-specialists. Ten (30%) countries and territories have met the WHO 2025 diagnosis coverage target of 60%, five (15%) have met the treatment target of 50%, and seven (21%) have met the needle and syringe exchange target. Although there are examples of countries and territories across the income spectrum meeting these targets, policy development in low-income and middle-income countries and territories generally lags behind that in high-income countries and territories.
AB - The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development for the elimination of viral hepatitis. To date, profiles from 33 countries and territories have been developed. These profiles reveal that 30 (91%) countries and territories have hepatitis C national action plans, 11 (33%) have systems to monitor hepatitis C-related mortality, 16 (48%) have systems to monitor hepatitis C incidence, and 18 (55%) have systems to track the number of people tested and treated. Some countries and territories continue to uphold barriers to hepatitis C treatment, with 12 (36%) still having partial or full restrictions on prescribing authority for non-specialists. Ten (30%) countries and territories have met the WHO 2025 diagnosis coverage target of 60%, five (15%) have met the treatment target of 50%, and seven (21%) have met the needle and syringe exchange target. Although there are examples of countries and territories across the income spectrum meeting these targets, policy development in low-income and middle-income countries and territories generally lags behind that in high-income countries and territories.
UR - https://www.scopus.com/pages/publications/105005654342
U2 - 10.1016/S2468-1253(25)00068-8
DO - 10.1016/S2468-1253(25)00068-8
M3 - Review article
AN - SCOPUS:105005654342
SN - 2468-1253
VL - 10
SP - 685
EP - 700
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
IS - 7
ER -